Overexpression of miR-216a/217 activated the PI3K/AKT and TGF-β pathways by targeting PTEN, and SMAD7 underlies hepatocarcinogenesis and tumor recurrence of hepatocarcinoma [115]. The gene discussed is TGFB1; the disease is neoplasm.